Medically Unexplained Symptoms
ð What is the scale of the problem
Enormous!!! Recent guidelines (referenced
below) suggest that
· Between 20% to 30% of consultations in primary
care are due to MUS
· Patients with MUS also take up 40% of medical
outpatient clinics, with enormous associated costs, iatrogenic harm and no
benefit
· Although the term ‘somatisation’ is unpopular with
patients, up to 70% of patients with MUS do also suffer from depression and/or
anxiety and in particular have high levels of health anxiety
· The research suggests that people are willing to
accept that psychological factors may be causing the MUS as long as we as
doctors keep an open mind. There is also an association with childhood adversity and abuse.
This is the easy bit! Physical symptoms with no clear explanation which have gone on for at least 3 months and affect functioning is the usual definition. If you like using questionnaire scores, the PHQ-15 score has been validated to help identify patients with somatisation disorder www.iapt.nhs.uk/silo/files/phq15.doc
Excellent guidelines for GPs for MUS were developed in 2011 by the Forum
for Mental Health in Primary Care, hosted by the RCGP and RCPsych.
http://www.nmhdu.org.uk/silo/files/guidance-for-health-professionals-on-medically-unexplained-symptoms-mus.pdf
They stress that the only therapy that may be needed is
the strength of the doctor patient relationship and continuity of care. Many
patients just need reassurance, a simple explanation that makes sense and removes
any blame from the patient and generates ideas about how to manage symptoms and
improve function. Key learning points
are:
· People need to be taken seriously. Showing
patients we believe them is crucial.
· Concentrate on managing symptoms and improving
function. Treat the treatable (e.g. associated depression, better pain control)
and refer for physical therapies to improve function. Recognise that MUS can also contribute towards impaired function in physical disease as well e.g. 60% of people with lung symptoms hyperventilate.
· Be pre-emptively reassuring, yet keep an open
mind and be willing to re-assess. Most MUS do resolve. 25% in primary care persist at 12 months.
· Not investigating may be the best option for the
patient. Investigating can give the impression we think something is wrong. If you expect the result to be normal, share
that at the outset. When referring and investigating pre-empt normal
results, and be very clear on the reason for the referral/investigation (eg to
exclude significant pathology)
· Enforcing psychosocial explanations will not
work as it encourages defensiveness. Allowing time and encouraging the patient
to make connections is much more effective.
The ‘reattribution model’ (Goldberg
& Gask) is encouraged
o Make
the patient feel understood
o Broaden
the agenda
o Negotiate
a new understanding of symptoms , including psychosocial factors
The evidence base is good that CBT helps MUS. In the NHS
the Improving Access to Psychological
Therapies programme have produced a positive practice guide for MUS,
strongly recommending commissioners to commission services and to encourage GPs
to refer for MUS.
The RCGP guide encourages us not to give a diagnosis
whatever, but to talk about functional conditions and being able to manage
symptoms. Neurosymptoms is an excellent self-help web-site on functional
symptoms, written by a neurologist with a special interest in MUS
Patients with MUS use up huge amounts of NHS resources. With an estimated annual cost of £3billion to the NHS, this is an area worth investing some cash! GPs
with their holistic knowledge of the patient, their finely honed communication
skills and their central role in co-ordinating care are the ideal people to
manage MUS. CBT is the intervention most shown to work. A recent pilot project
suggests that referring patients with MUS to a primary care, GP led symptoms
clinic to see a GP with CBT training and dedicated, longer appointments
is feasible and may improve outcomes. I would love to see a GP led clinic like
this I could refer patients to and indeed would even be interested in working
in one should it appear!
Conclusion: Recognition and management of MUS is part of what makes General Practice so fascinating, and yet also so challenging. These resources can help us rise to this challenge to help patients. If you have any other good tips or resources do please
share!
NB Since this blog there have been new evidence-based guidelines on MUS published, see